Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

271
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
271
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

260
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
260

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A case of atypical orf virus infection of the hand in an immunocompromised patient.

Skeletal radiology·2026
Same author

Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipients.

The Journal of infection·2026
Same author

Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled study.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

Asymptomatic Bacteriuria in Kidney Transplant: Approaches to Screening and Treatment-A National Survey of Canadian Nephrologists.

Clinical transplantation·2026
Same author

Understanding atrial failure: from diagnosis to clinical implications.

Nature reviews. Cardiology·2026
Same author

Comparative Strategies to Overcome Diuretic Resistance in Heart Failure: A Network Meta-Analysis.

JACC. Advances·2026

Related Experiment Video

Updated: May 9, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.7K

Moving Beyond the Perfect Donor: An Interdisciplinary Approach to Optimizing Donor Utilization.

Aditi Venkatraman1, Lebei Pi2, David Belzile3

  • 1Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada; Ajmera Transplant Centre, University Health Network, Toronto, Ontario, Canada.

JACC. Advances
|May 1, 2025
PubMed
Summary
This summary is machine-generated.

Implementing targeted interventions doubled donor heart utilization to 18.5% and reduced missed viable opportunities to 8.6%. This study improved heart transplant efficiency without negatively impacting patient outcomes.

Keywords:
donor managementdonor utilizationheart transplantation

More Related Videos

Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

731
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

567

Related Experiment Videos

Last Updated: May 9, 2025

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
09:54

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death

Published on: August 15, 2022

1.7K
Study of Experimental Organ Donation Models for Lung Transplantation
08:56

Study of Experimental Organ Donation Models for Lung Transplantation

Published on: March 15, 2024

731
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

567

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Organ Donation

Background:

  • Significant wastage of viable donor hearts in North America due to current acceptance practices.
  • Growing demand for donor hearts for transplantation.
  • Need for improved strategies to maximize donor heart utilization.

Purpose of the Study:

  • To increase donor heart utilization rate to 20%.
  • To reduce missed viable donor heart opportunities to ≤10%.
  • To assess the impact of interventions on primary graft dysfunction.

Main Methods:

  • Prospective single-center study (2021-2023) analyzing donor heart offers.
  • Defined missed viable opportunities by specific donor criteria (e.g., LVEF, age, ischemic time).
  • Implemented interventions: real-time utilization dashboard, international speaker series, and donor report cards.

Main Results:

  • Donor heart utilization increased from 12.4% (preintervention) to 18.5% (postintervention) (P=0.038).
  • Missed viable opportunities significantly decreased from 19.3% to 8.6% (P<0.001).
  • A trend towards reduced severe primary graft dysfunction was observed postintervention (26% vs 12%, P=0.121).

Conclusions:

  • Interdisciplinary, multipronged interventions effectively doubled donor heart utilization.
  • Significant reduction in missed viable opportunities achieved.
  • Short-term heart transplant recipient outcomes were not compromised by the interventions.